Coumarin Resistance

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Description

Warfarin is a widely prescribed anticoagulant for the prevention of thromboembolic diseases for subjects with deep vein thrombosis, atrial fibrillation, or mechanical heart valve replacement (Yuan et al., 2005). The dose requirement is highly variable, both interindividually and interethnically.Variation in the VKORC1 gene is believed to be the most important individual predictor of warfarin dose, accounting for about 30% of the variance observed in dosing (Ross et al., 2010).

Genes related to Coumarin Resistance

VKORC1
CYP2C9
F9

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Coumarin Resistance

Abnormality of metabolism/homeostasis
Atrial fibrillation
Abnormality of blood and blood-forming tissues
Deep venous thrombosis

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Coumarin Resistance Is also known as coumarin, poor metabolism of, warfarin resistance.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Coumarin Resistance Recommended genes panels

Panel Name, Specifity and genes Tested/covered
VKORC1 Sequencing. By Cincinnati Children's Hospital Medical Center Laboratory of Genetics and Genomics Cincinnati Children's Hospital Medical Center (United States). VKORC1 Specificity 100 % Genes 34 %
Warfarin resistance. By Sheffield Diagnostic Genetics Service Sheffield Children's NHS Foundation Trust (United Kingdom). VKORC1 Specificity 100 % Genes 34 %
Vitamin K-Dependent Clotting Factors, Combined Deficiency of, 2. By CGC Genetics (Portugal). VKORC1 Specificity 100 % Genes 34 %
Susceptibility to warfarin (CYP2C9 and VKORC1 genes). By CGC Genetics (Portugal). VKORC1, CYP2C9 Specificity 100 % Genes 67 %
Pharmacogenetic panel for cardiology. By CGC Genetics (Portugal). VKORC1, CYP2C19, CYP2C9, CYP2D6 Specificity 50 % Genes 67 %
Hereditary combined deficiency of vitamin K-dependent clotting factors, type 2 (sequence analysis of VKORC1 gene). By CGC Genetics (Portugal). VKORC1 Specificity 100 % Genes 34 %
Warfarin resistance (sequence analysis of VKORC1 gene). By CGC Genetics (Portugal). VKORC1 Specificity 100 % Genes 34 %
Warfarin resistance (sequence analysis of VKORC1 gene). By CGC Genetics (Portugal). VKORC1 Specificity 100 % Genes 34 %

You can get up to 106 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Search Engine

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like MISMATCH REPAIR CANCER SYNDROME; MMRCS FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2 EPIPHYSEAL DYSPLASIA, MULTIPLE, 3; EDM3 AMELOGENESIS IMPERFECTA, TYPE IIIA; AI3A OGDEN SYNDROME; OGDNS